DarioHealth Corp

DRIO NASDAQ Healthcare & Biotech Monde US23725P2092
7.20 $
1.23 %

DarioHealth Corp is a digital health company that develops mobile solutions for managing diabetes and other chronic conditions.

Performance & Momentum

6 Months 40.27 %
1 Year 47.92 %
3 Years 90.65 %
5 Years 98.34 %

Strategic Analysis

DarioHealth Corp is positioned in the digital health market, offering innovative mobile solutions for diabetes management and chronic disease care, benefiting from the growth in personalized medical . Its business model is built on technological integration designed to improve patient autonomy and care efficiency in a sector undergoing rapid transformation.

Strengths
  • Specialization in a promising segment of digital health dedicated to chronic diseases
  • Technological expertise in developing mobile applications tailored to patient needs
Weaknesses
  • Very poor long-term stock performance, raising questions about its economic viability
  • Lack of recent catalysts or positive news to revive momentum
Momentum

Momentum is currently neutral to weak, reflecting a phase of stagnation and a persistent decline over several years. This trend calls for heightened caution, due to a lack of positive signals and a demanding competitive environment in digital health.

Similar stocks to DarioHealth Corp

Anantys Community

Be the first to share your analysis on DarioHealth Corp.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases